8-K: DUKE Robotics Secures $750K Private Placement

DUKE Robotics Corp. announced a $750,000 private placement of common stock and warrants, bolstering its balance sheet for key operational and commercialization initiatives.

Summary

• DUKE Robotics Corp. entered into Securities Purchase Agreements on December 30, 2025, with seven (7) non-U.S. investors for a private placement offering.
• The Company agreed to issue and sell an aggregate of 2,083,333 shares of common stock at a price of $0.36 per share.
• Warrants to purchase an additional 2,083,333 shares of common stock were also issued, with an exercise price of $0.65 per share.
• The warrants are exercisable immediately and expire on November 30, 2026, but may be extended to May 30, 2028, if a public offering or other qualifying financing of at least $2,500,000 has not occurred by the initial expiration date.
• The aggregate gross proceeds from the offering are approximately $750,000, with the closing expected on January 6, 2026.
• Proceeds will be utilized for general corporate purposes and working capital, specifically supporting operational and commercialization initiatives.
• A make-whole provision is included, entitling investors to additional shares if the Company conducts a firm-commitment underwritten public offering on a major stock exchange by November 30, 2026, at a price per share (after a 20% discount) less than the $0.36 purchase price.
• The securities issued are exempt from registration requirements under Section 4(a)(2) and/or Rule 506(b) of Regulation D and Regulation S of the Securities Act of 1933.

Sentiment

Score: 7

Explanation: The capital raise provides necessary funding for operations and commercialization, and the 'premium to market' pricing, along with participation from long-time investors, suggests a positive reception despite the company's limited financial resources and OTCQB listing. The make-whole provision, while a potential future dilution, also offers some protection to current investors.

Positives

• Successfully raised $750,000 in gross proceeds through a private placement, strengthening the balance sheet.
• The financing was described as 'premium-priced' and 'at a premium to market' in the press release, suggesting favorable terms.
• Participation from existing long-time investors indicates continued confidence and support for the Company.
• The capital infusion is earmarked to support ongoing operational and commercialization initiatives, which are crucial for growth.

Negatives

• The need for a capital raise suggests that existing cash flow or reserves may be insufficient to fully fund planned operational and commercialization initiatives.
• The Company's common stock trades on the OTCQB, which typically implies lower liquidity and higher investment risk compared to major exchanges.
• The make-whole provision in the Securities Purchase Agreement could lead to future dilution for existing shareholders if a subsequent public offering occurs at a lower effective price.

Risks

• Risks related to the successful market adoption of the Company's technologies.
• Risks associated with the continued development and refinement of the Company's technology.
• Fluctuations in foreign currency exchange rates could impact financial results.
• Operational challenges related to marketing activities in new markets.
• Economic conditions may affect defense spending and infrastructure investment, impacting demand for products.
• Geopolitical factors could disrupt business operations.
• Regulatory challenges in various regions may hinder market entry or operations.
• Competition from technological advances poses a threat to market share and product relevance.
• Investment in the Securities is speculative and involves a high degree of risk of loss.
• Substantial restrictions on the transferability of the Securities, making it difficult to liquidate the investment.
• The Company has very limited financial resources, implying a significant risk of complete loss of investment.

Future Outlook

The Company expects to use the net proceeds from the private placement for general corporate purposes and working capital, specifically to support ongoing operational and commercialization initiatives. Management anticipates continued development and refinement of its technology and successful market adoption of its solutions.

Management Comments

• "Duke Robotics Announces $750,000 Private Placement at a Premium to Market."
• "Premium-Priced Financing with Participation from Long-Time Investors Strengthens Balance Sheet and is Expected to Support Near-Term Execution Opportunities the Company is Targeting."
• "The Company intends to use the net proceeds from the private placement for working capital, and general corporate purposes, including supporting ongoing operational and commercialization initiatives the Company is pursuing."

Industry Context

DUKE Robotics operates in the advanced robotics and autonomous drone sectors, serving both civilian (insulator cleaning) and defense markets (weaponized drones via Elbit Systems). This capital raise provides essential funds for continued research, development, and commercialization in these high-growth, technology-intensive industries. The defense sector is influenced by geopolitical factors and government spending, while civilian applications like infrastructure maintenance offer new market opportunities for specialized drone solutions. The funding aims to enhance the Company's competitive position and accelerate market penetration.

Stakeholder Impact

• Shareholders: Existing shareholders face potential dilution from the issuance of new shares and warrants, and further dilution if warrants are exercised or the make-whole provision is triggered. However, the capital raise strengthens the company's financial position, potentially supporting growth and future value.
• Investors (in this offering): Receive common stock and warrants at a 'premium to market' price, with a make-whole provision offering some downside protection. Their investment supports the company's strategic initiatives.
• Employees: Continued funding supports ongoing operations and commercialization, potentially securing jobs and future growth opportunities.
• Customers: Enhanced financial stability may lead to continued product development and improved service delivery for both civilian (Insulator Cleaning Drone) and defense (Bird of Prey) markets.
• Creditors: A strengthened balance sheet may improve the company's creditworthiness.

Next Steps

• Closing of the private placement offering, expected on January 6, 2026.
• Utilization of proceeds for general corporate purposes and working capital, including operational and commercialization initiatives.
• Continued development and refinement of the Company's advanced robotics and drone technologies.
• Efforts towards successful market adoption of the Company's technologies in both civilian and defense sectors.
• Potential future public offering or qualifying financing of at least $2,500,000 by November 30, 2026, which could impact warrant expiration.

Key Dates

Recommendation

While the capital raise at a 'premium to market' and the participation of long-time investors are positive signals, the company's limited financial resources, OTCQB listing, and the inherent risks in technology development and market adoption suggest a 'hold' rather than a 'buy.' The funding provides a runway for operations and commercialization, but significant upside is contingent on successful execution in highly competitive and regulated markets. Investors should monitor progress on commercialization initiatives and financial performance before considering further investment.

Keywords

DUKE Robotics, DUKR, Private Placement, Equity Financing, Warrants, Robotics, Drones, Autonomous Systems, Defense Technology, Insulator Cleaning Drone, Capital Raise, SEC Filing, Form 8-K, OTCQB